TCL Archive Competing Core, P01 Grants Held To 7% Increases To Help Spread $$ Around December 7, 1979
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003